Strata Skin Scien Cmn (SSKN) 0.51 $SSKN STRATA
Post# of 273254
Posted On: 09/21/2016 1:13:08 AM
Strata Skin Scien Cmn (SSKN) 0.51 $SSKN
STRATA Skin Sciences Reports Second Quarter 2016 Financial Results
GlobeNewswire - Thu Aug 11, 3:00PM CDT
STRATA Skin Sciences, Inc. ("STRATA"
(NASDAQ:SSKN) a medical technology company dedicated to developing and commercializing innovative products for the treatment and diagnosis of serious dermatological disorders, today reported financial results for the quarter ended June 30, 2016.
SSKN: 0.51 (-0.01)
STRATA Skin Sciences, Inc. to Report 2nd Quarter 2016 Financial Results on Thursday, August 11
GlobeNewswire - Thu Jul 28, 7:02AM CDT
STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing and commercializing innovative products for the diagnosis and treatment of serious dermatological disorders, will release second quarter financial results on Thursday, August 11, after the market close. STRATA Skin Sciences President and Chief Executive Officer, Michael Stewart, and Christina Allgeier, Chief Financial Officer, will host a conference call at 4:30 pm Eastern Time to review the Company's progress and answer questions.
SSKN: 0.51 (-0.01)
STRATA Skin Sciences to Host Key Opinion Leader Lunch
GlobeNewswire - Mon Jun 13, 7:07AM CDT
STRATA Skin Sciences, Inc. (NASDAQ:SSKN) ("STRATA" a medical technology company dedicated to developing and commercializing innovative products for the treatment and diagnosis of dermatological disorders, announced today that it will host a Key Opinion Leader meeting on Thursday, June 16th at 12pm ET in New York City.
SSKN: 0.51 (-0.01)
STRATA Skin Sciences Reports First Quarter 2016 Financial Results
GlobeNewswire - Thu May 12, 3:01PM CDT
STRATA Skin Sciences, Inc. (NASDAQ:SSKN) ("STRATA" a medical technology company dedicated to developing and commercializing innovative products for the treatment and diagnosis of serious dermatological disorders, today reported financial results for the quarter ended March 31, 2016.
SSKN: 0.51 (-0.01)
LifeSci Capital Initiates Coverage of STRATA Skin Sciences
ACCESSWIRE - Mon May 02, 9:18AM CDT
Commercializing Products for Patients with Serious Dermatological Disorders; Report Available here: http://www.lifescicapital.com/equity-research/strata-skin/
SSKN: 0.51 (-0.01)
STRATA Skin Sciences, Inc. to Report 1st Quarter 2016 Financial Results on Thursday, May 12
GlobeNewswire - Fri Apr 29, 8:40AM CDT
STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing and commercializing innovative products for the diagnosis and treatment of serious dermatological disorders, will release first quarter financial results on Thursday, May 12, after the market close. STRATA Skin Sciences President and Chief Executive Officer, Michael Stewart, and Christina Allgeier, Chief Financial Officer, will host a conference call at 4:30 pm Eastern Time to review the Company's progress and answer questions.
SSKN: 0.51 (-0.01)
STRATA Skin Sciences Reports Second Quarter 2016 Financial Results
GlobeNewswire - Thu Aug 11, 3:00PM CDT
STRATA Skin Sciences, Inc. ("STRATA"
(NASDAQ:SSKN) a medical technology company dedicated to developing and commercializing innovative products for the treatment and diagnosis of serious dermatological disorders, today reported financial results for the quarter ended June 30, 2016. SSKN: 0.51 (-0.01)
STRATA Skin Sciences, Inc. to Report 2nd Quarter 2016 Financial Results on Thursday, August 11
GlobeNewswire - Thu Jul 28, 7:02AM CDT
STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing and commercializing innovative products for the diagnosis and treatment of serious dermatological disorders, will release second quarter financial results on Thursday, August 11, after the market close. STRATA Skin Sciences President and Chief Executive Officer, Michael Stewart, and Christina Allgeier, Chief Financial Officer, will host a conference call at 4:30 pm Eastern Time to review the Company's progress and answer questions.
SSKN: 0.51 (-0.01)
STRATA Skin Sciences to Host Key Opinion Leader Lunch
GlobeNewswire - Mon Jun 13, 7:07AM CDT
STRATA Skin Sciences, Inc. (NASDAQ:SSKN) ("STRATA"
a medical technology company dedicated to developing and commercializing innovative products for the treatment and diagnosis of dermatological disorders, announced today that it will host a Key Opinion Leader meeting on Thursday, June 16th at 12pm ET in New York City. SSKN: 0.51 (-0.01)
STRATA Skin Sciences Reports First Quarter 2016 Financial Results
GlobeNewswire - Thu May 12, 3:01PM CDT
STRATA Skin Sciences, Inc. (NASDAQ:SSKN) ("STRATA"
a medical technology company dedicated to developing and commercializing innovative products for the treatment and diagnosis of serious dermatological disorders, today reported financial results for the quarter ended March 31, 2016. SSKN: 0.51 (-0.01)
LifeSci Capital Initiates Coverage of STRATA Skin Sciences
ACCESSWIRE - Mon May 02, 9:18AM CDT
Commercializing Products for Patients with Serious Dermatological Disorders; Report Available here: http://www.lifescicapital.com/equity-research/strata-skin/
SSKN: 0.51 (-0.01)
STRATA Skin Sciences, Inc. to Report 1st Quarter 2016 Financial Results on Thursday, May 12
GlobeNewswire - Fri Apr 29, 8:40AM CDT
STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing and commercializing innovative products for the diagnosis and treatment of serious dermatological disorders, will release first quarter financial results on Thursday, May 12, after the market close. STRATA Skin Sciences President and Chief Executive Officer, Michael Stewart, and Christina Allgeier, Chief Financial Officer, will host a conference call at 4:30 pm Eastern Time to review the Company's progress and answer questions.
SSKN: 0.51 (-0.01)
(0)
(0)Scroll down for more posts ▼